Cargando…

Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer

Endometrial cancer is now recognized to be several diseases with differing biology and responses to treatment. Improved molecular characterization has furthered the development and testing of targeted therapies in the different cohorts of endometrial cancer. Lessons are being learned from other canc...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chambers, Setsuko K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599945/ https://www.ncbi.nlm.nih.gov/pubmed/36291804 http://dx.doi.org/10.3390/cancers14205020

Ejemplares similares

Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium
por: Wang, Yiying, et al.
Publicado: (2013)

Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer?
por: Kleeff, Jörg, et al.
Publicado: (2019)

The use of neoadjuvant chemotherapy in advanced endometrial cancer
por: Philp, L., et al.
Publicado: (2021)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
por: Akhtari, Mani, et al.
Publicado: (2016)

Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer
por: Patel, Amol, et al.
Publicado: (2020)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Evaluation of the optimal sequence of adjuvant chemotherapy and radiation therapy in the treatment of advanced endometrial cancer
por: McEachron, Jennifer, et al.
Publicado: (2020)

Obesity Epidemic—The Underestimated Risk of Endometrial Cancer
por: Kiesel, Ludwig, et al.
Publicado: (2020)

Current and Future Roles of Targeted Therapy and Immunotherapy in Advanced Melanoma
por: Olszanski, Anthony J.
Publicado: (2014)

Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand?
por: Grivas, Nikolaos K.
Publicado: (2019)

Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials
por: Lv, Jia-Wei, et al.
Publicado: (2019)

Cancer biomarkers and targeted therapies
por: Shen, Zhiyuan
Publicado: (2013)

Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy
por: Ezewuiro, Obiageli, et al.
Publicado: (2016)

Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
por: Huang, Allan B., et al.
Publicado: (2021)

Are endometrial cancer clinical practice management guidelines sufficiently consumer centric?
por: Obermair, Andreas, et al.
Publicado: (2022)

Sentinel node mapping in endometrial cancer
por: Bogani, Giorgio, et al.
Publicado: (2019)

Conversion therapy for advanced cholangiocarcinoma in the era of molecular targeted therapy and immune therapy
por: Zhang, Zunyi, et al.
Publicado: (2023)

Promising clinical practices of metformin in women with PCOS and early-stage endometrial cancer
por: Shao, Ruijin, et al.
Publicado: (2014)

New therapies for advanced, recurrent, and metastatic endometrial cancers
por: Makker, Vicky, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020)

Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma
por: Egawa‐Takata, Tomomi, et al.
Publicado: (2022)

Pancreatic Cancer: Targeted Therapy Holds the Promise
por: Zhou, Zhijun, et al.
Publicado: (2021)

Robotic surgery in early-stage endometrial cancer
por: Corrado, Giacomo, et al.
Publicado: (2019)

Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists
por: Zheng, Wenxin
Publicado: (2023)

Targeted Treatment of Advanced Endometrial Cancer: Focus on Pembrolizumab
por: El-ghazzi, Nathan, et al.
Publicado: (2023)

Advancing novel therapies for ichthyoses
por: Schmuth, M., et al.
Publicado: (2020)

Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
por: Karachaliou, Niki, et al.
Publicado: (2015)

Novel mechanism of resistance to targeted therapies in lung cancer
por: Wang, Walter, et al.
Publicado: (2018)

Disulfidptosis: a new target for metabolic cancer therapy
por: Zheng, Peijie, et al.
Publicado: (2023)

Chemoresistance and targeted therapies in ovarian and endometrial cancers
por: Brasseur, Kevin, et al.
Publicado: (2016)

Whither high-dose chemotherapy in breast cancer?
por: Mayer, Astrid, et al.
Publicado: (2001)

The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy
por: Visconti, Roberta, et al.
Publicado: (2017)

Beta-adrenergic signaling, a novel target for cancer therapy?
por: Schuller, Hildegard M.
Publicado: (2010)

Hypoxia-specific targets in cancer therapy: role of splice variants
por: Vordermark, Dirk
Publicado: (2010)

RNA nanoparticles for targeted therapies of triple-negative breast cancers
por: Danai, Leyla, et al.
Publicado: (2023)

Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients by Halama et al
por: Deming, Dustin A.
Publicado: (2016)

Sequential Chemotherapy and Radiotherapy in the Sandwich Method for Advanced Endometrial Cancer: A Meta-Analysis
por: Gao, Huiqiao, et al.
Publicado: (2015)

Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy.
por: Onda, T., et al.
Publicado: (1997)

Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
por: Zhang, Yaxiong, et al.
Publicado: (2018)

Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
por: Wang, Yaoqun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6ti18u34snv4db2loaeqe7ph4n